ATE519777T1 - Magnetosomen-genexpression in eukaryotischen zellen - Google Patents

Magnetosomen-genexpression in eukaryotischen zellen

Info

Publication number
ATE519777T1
ATE519777T1 AT07719932T AT07719932T ATE519777T1 AT E519777 T1 ATE519777 T1 AT E519777T1 AT 07719932 T AT07719932 T AT 07719932T AT 07719932 T AT07719932 T AT 07719932T AT E519777 T1 ATE519777 T1 AT E519777T1
Authority
AT
Austria
Prior art keywords
eukaryotic cells
gene expression
magnetosome
magnetosome gene
structures
Prior art date
Application number
AT07719932T
Other languages
English (en)
Inventor
Frank Prato
Donna Goldhawk
Cheryl Mccreary
Rebecca Mcgirr
Savita Dhanvantari
Terry Thompson
Alex Thomas
David Hill
Original Assignee
Multi Magnetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multi Magnetics Inc filed Critical Multi Magnetics Inc
Application granted granted Critical
Publication of ATE519777T1 publication Critical patent/ATE519777T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT07719932T 2006-06-08 2007-06-08 Magnetosomen-genexpression in eukaryotischen zellen ATE519777T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81178406P 2006-06-08 2006-06-08
US87979107P 2007-01-11 2007-01-11
PCT/CA2007/001016 WO2007140617A1 (en) 2006-06-08 2007-06-08 Magnetosome gene expression in eukaryotic cells

Publications (1)

Publication Number Publication Date
ATE519777T1 true ATE519777T1 (de) 2011-08-15

Family

ID=38801022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07719932T ATE519777T1 (de) 2006-06-08 2007-06-08 Magnetosomen-genexpression in eukaryotischen zellen

Country Status (6)

Country Link
US (1) US9556238B2 (de)
EP (1) EP2029754B1 (de)
AT (1) ATE519777T1 (de)
AU (1) AU2007257180A1 (de)
CA (1) CA2655118C (de)
WO (1) WO2007140617A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0812191D0 (en) * 2008-07-03 2008-08-13 Greater Glasgow Health Board Modified cells and methods of monitoring their viability
US8580230B2 (en) 2009-02-23 2013-11-12 Kent State University Materials and methods for MRI contrast agents and drug delivery
US9719146B2 (en) 2009-09-09 2017-08-01 General Electric Company Composition and method for imaging stem cells
CN102811726B (zh) * 2009-11-18 2015-03-18 纳米细菌公司 通过由提取自趋磁细菌并经受交变磁场的磁小体的各种链所产生的热的释放诱导的癌症或肿瘤的治疗
US9023612B2 (en) 2012-01-13 2015-05-05 Bell Biosystems, Inc. Eukaryotic cells with artificial endosymbionts for multimodal detection
US10076579B2 (en) 2012-01-13 2018-09-18 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8828681B2 (en) 2012-01-13 2014-09-09 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8956873B2 (en) 2012-01-13 2015-02-17 Bell Biosystems, Inc. Host cells with artificial endosymbionts
WO2014145785A1 (en) 2013-03-15 2014-09-18 Bell Biosystems, Llc Host cells with artificial endosymbionts
JP2016528928A (ja) 2013-09-03 2016-09-23 ベル・バイオシステムズ，インコーポレーテッド 人工内部共生体を用いた宿主細胞の改変入
WO2015127527A1 (en) * 2014-02-25 2015-09-03 Lawson Health Research Institute Co-expression of magnetotactic bacterial genes and genes encoding iron handling proteins in cells
EP3747467A3 (de) * 2019-06-03 2021-03-03 Nanobacterie Kryosystem mit nanopartikeln zur behandlung eines körperteils eines individuums durch kryotherapie
WO2021076551A1 (en) * 2019-10-14 2021-04-22 University Of Cincinnati Novel rna aptamer intervenes estrogen receptor interaction with coactivator med1 to overcome breast cancer metastasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62275679A (ja) 1986-05-23 1987-11-30 Tdk Corp 磁気微粒子含有細胞の製法
US5861285A (en) 1994-09-16 1999-01-19 Tdk Corporation Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest
DE19716732C2 (de) 1997-03-07 1999-03-25 Max Delbrueck Centrum Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2002176989A (ja) * 2000-12-14 2002-06-25 Japan Science & Technology Corp 磁気微粒子膜特異的タンパク質
US20090311194A1 (en) * 2005-04-29 2009-12-17 Emory University Methods and compositions for the production and use of magnetosomes

Also Published As

Publication number Publication date
WO2007140617A1 (en) 2007-12-13
EP2029754A1 (de) 2009-03-04
CA2655118C (en) 2015-10-06
US9556238B2 (en) 2017-01-31
CA2655118A1 (en) 2007-12-13
AU2007257180A1 (en) 2007-12-13
EP2029754B1 (de) 2011-08-10
US20100297022A1 (en) 2010-11-25
EP2029754A4 (de) 2009-07-08

Similar Documents

Publication Publication Date Title
ATE519777T1 (de) Magnetosomen-genexpression in eukaryotischen zellen
IL294095B1 (en) Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
HRP20182135T1 (hr) Pripravci za i postupci liječenja poremećaja povezanih s ige
EP2257155A4 (de) Kryokonservierung von biologischen zellen und geweben
CY2017018I2 (el) Παρασκευη ενεργων, ακρως φωσφορυλιωμενων, ανθρωπινων λυσοσωμικων ενζυμων σουλφατασης και χρησεις αυτων
AR081868A1 (es) Vectores y secuencias de sulfamidasa humana para el tratamiento de mucopolisacaridosis
WO2006084209A3 (en) Rnai expression constructs
UY31816A (es) Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras
PL2506857T3 (pl) DOSTARCZANIE mRNA DLA ZWIĘKSZENIA ILOŚCI BIAŁEK I ENZYMÓW W LUDZKICH CHOROBACH GENETYCZNYCH
EP2504469A4 (de) Elektrolytlösung und elektropolierverfahren
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
EP2515867A4 (de) Kollagen und hyaluronan mit zellgewebegel
MX377802B (es) Metodos y composiciones para trastornos del sueño y otros trastornos.
EP2356446A4 (de) Therapeutische und diagnostische verfahren im zusammenhang mit krebsstammzellen
EP2262519A4 (de) Behandlung von gehör- und gleichgewichtsstörungen mit redoxaktiven therapeutika
GB0920703D0 (en) Compositions containing satiogens and methods of use
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
BRPI0923015A2 (pt) enxertos ósseos com atividade de protease reduzida e métodos de seleção e uso
EP2417271A4 (de) Verfahren zur vorhersage eines krebsrisikos mithilfe einer genexpression in prämalignem gewebe
HRP20150117T1 (xx) Pripravci kolagenaze g i kolagenaze h za lijeäśenje bolesti koje ukljuäśuju promjene kolagena
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
MX2012002909A (es) Metodos y composiciones para su uso en diagnostico de pacientes con cancer.
EP2262777B8 (de) 1-benzyl-3-hydroxymethylindazolderivate und ihre verwendung bei der behandlung von auf der expression von mcp-1 und cx3cr1 basierten erkrankungen
EP2099465A4 (de) Reishi-vermittelte verstärkte adhäsion und differenzierung menschlicher gewebevorläuferzellen
MY179250A (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties